What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Participants should self administer the preparation within 45 minutes, dissolving 100g of powder in 1L of water”In the company’s words, NCT07465705 on ClinicalTrials.gov
- Tested for
- Elective Colonoscopy
- Main trialPhase 3
- “This is a study to test the non-inferiority of bowel cleansing with 100 g Mannitol against standard Plenvu® same-day dosing regimen. The 50% of the subjects will receive Mannitol, while the remaining part will receive Plenvu®.”In the company’s words, NCT07465705 on ClinicalTrials.gov
Other drugs for Elective Colonoscopy
- InfigratinibQED Therapeutics, a BridgeBio company · Phase 2/3
- GaretosmabRegeneron · Phase 3
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 31 Mar 2026 | Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026